Empowering Muscles, Empowering Lives
Cytokinetics is a late-stage pharmaceutical company focused on discovering, developing and commercializing potential treatments for people with debilitating diseases in which muscle performance is compromised, such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA) and heart failure.
We worked with Cytokinetics to rebrand the company and refine its strategic positioning to reflect its position as a leader in the muscle biology space with an advancing pipeline and high-profile partnerships. The rebranding included new design for the Cytokinetics brand identity and website to echo the company’s refreshed messaging.
To help Cytokinetics stay up-to-date on the current ALS, SMA and heart failure landscapes, we delivered ongoing quarterly analytics reports and did an in-depth social listening project to get a deeper understanding of the ALS community from the patient, healthcare provider and caregiver perspectives. In addition to these activities, we supported Cytokinetics’ corporate communications and media outreach efforts on an ongoing basis and developed the concept for the company’s trade show booth, which included scripting and art direction for the booth’s interactive educational elements.